These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15250512)
1. Dynamics of bacterial carriage and disease: lessons from the meningococcus. Maiden MC Adv Exp Med Biol; 2004; 549():23-9. PubMed ID: 15250512 [No Abstract] [Full Text] [Related]
2. Uncloaking the meningococcus: dynamics of carriage and disease. Stephens DS Lancet; 1999 Mar; 353(9157):941-2. PubMed ID: 10459897 [No Abstract] [Full Text] [Related]
3. Rise in Group W Meningococcal Carriage in University Students, United Kingdom. Oldfield NJ; Cayrou C; AlJannat MAK; Al-Rubaiawi AAA; Green LR; Dada S; Steels OD; Stirrup C; Wanford J; Atwah BAY; Bayliss CD; Turner DPJ Emerg Infect Dis; 2017 Jun; 23(6):1009-1011. PubMed ID: 28518025 [TBL] [Abstract][Full Text] [Related]
4. Toward a meningitis-free world. Black S; Pizza M; Nissum M; Rappuoli R Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923 [TBL] [Abstract][Full Text] [Related]
7. Microbiology. A furtive pathogen revealed. Nassif X Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929 [No Abstract] [Full Text] [Related]
8. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Jodar L; Cartwright K; Feavers IM Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447 [No Abstract] [Full Text] [Related]
9. A vaccine against meningitis in Africa. Lancet Infect Dis; 2011 Jan; 11(1):1. PubMed ID: 21183138 [No Abstract] [Full Text] [Related]
12. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis. Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105 [TBL] [Abstract][Full Text] [Related]
13. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. MenAfriCar consortium J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Noronha CP; Struchiner CJ; Halloran ME Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of BC meningococcal vaccine in Brazil. Nishioka S Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501 [No Abstract] [Full Text] [Related]
16. Susceptibility to meningococcal meningitis. Sabath LD; Rosner B N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552 [No Abstract] [Full Text] [Related]
17. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine]. Del Real G Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419 [No Abstract] [Full Text] [Related]
18. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056 [TBL] [Abstract][Full Text] [Related]